Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 5 trials

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
P 3 (1)
P 4 (1)

Trial Status

Not Yet Recruiting2
Active Not Recruiting1
Enrolling By Invitation1
Recruiting1

Clinical Trials (5)

Showing 5 of 5 trials
NCT07543562Phase 3Recruiting

Selenium Intervention Registry Randomized Trial in Heart Failure

NCT07467668Not ApplicableNot Yet Recruiting

Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure

NCT07442448Phase 4Enrolling By Invitation

Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure

NCT07275437Not ApplicableNot Yet Recruiting

Effectiveness and Safety of Uptitration of Guideline Directed MEdical Therapy in Heart Failure With Reduced Ejection Fraction With Limited Kidney Function Assessments

NCT07071142Active Not Recruiting

Frailty and Outcomes in Older Heart Failure Patients With Ejection Fraction >40%

Showing all 5 trials

Research Network

Activity Timeline